Bluejay Diagnostics, Inc. (BJDX) stock
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.15−0.14 (-5.90%)
Close on Nov 17, 2026Market cap $9.63MP/E –Yield –
Bluejay Diagnostics total assets
Total assets on the balance sheet at the end of each period.
Bluejay Diagnostics's total assets was $11.53M at Jun 30, 2026. For fiscal 2025 it was $7.12M, up 6.9% from the year before. The highest annual figure on record is $21.02M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.12M | +6.9% |
| FY2024 | Dec 31, 2024 | $6.66M | +36.7% |
| FY2023 | Dec 31, 2023 | $4.87M | -64.0% |
| FY2022 | Dec 31, 2022 | $13.52M | -35.7% |
| FY2021 | Dec 31, 2021 | $21.02M | +1285.3% |
| FY2020 | Dec 31, 2020 | $1.52M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.53M | +80.1% |
| Q1 FY2026 | Mar 31, 2026 | $5.60M | +6.1% |
| Q4 FY2025 | Dec 31, 2025 | $7.12M | +6.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.89M | -41.5% |
| Q2 FY2025 | Jun 30, 2025 | $6.40M | -41.0% |
| Q1 FY2025 | Mar 31, 2025 | $5.28M | +4.0% |
| Q4 FY2024 | Dec 31, 2024 | $6.66M | +36.7% |
| Q3 FY2024 | Sep 30, 2024 | $8.35M | +1.3% |
| Q2 FY2024 | Jun 30, 2024 | $10.86M | +28.1% |
| Q1 FY2024 | Mar 31, 2024 | $5.08M | -53.4% |
| Q4 FY2023 | Dec 31, 2023 | $4.87M | -64.0% |
| Q3 FY2023 | Sep 30, 2023 | $8.25M | -47.5% |
| Q2 FY2023 | Jun 30, 2023 | $8.48M | -53.1% |
| Q1 FY2023 | Mar 31, 2023 | $10.89M | -45.8% |
| Q4 FY2022 | Dec 31, 2022 | $13.52M | -35.7% |
| Q3 FY2022 | Sep 30, 2022 | $15.71M | +333.5% |
| Q2 FY2022 | Jun 30, 2022 | $18.07M | +1090.7% |
| Q1 FY2022 | Mar 31, 2022 | $20.08M | – |
| Q4 FY2021 | Dec 31, 2021 | $21.02M | – |
| Q3 FY2021 | Sep 30, 2021 | $3.62M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.52M | – |
See a number that looks wrong?